Narrative review: reversible cerebral vasoconstriction syndromes

LH Calabrese, DW Dodick, TJ Schwedt… - Annals of internal …, 2007 - acpjournals.org
Reversible cerebral vasoconstriction syndromes (RCVS) comprise a group of diverse
conditions, all characterized by reversible multifocal narrowing of the cerebral arteries …

National Institute of Neurological Disorders and Stroke consensus diagnostic criteria for traumatic encephalopathy syndrome

DI Katz, C Bernick, DW Dodick, J Mez, ML Mariani… - Neurology, 2021 - AAN Enterprises
Objective To develop evidence-informed, expert consensus research diagnostic criteria for
traumatic encephalopathy syndrome (TES), the clinical disorder associated with …

A phase‐by‐phase review of migraine pathophysiology

DW Dodick - Headache: the journal of head and face pain, 2018 - Wiley Online Library
Migraine is a common, disabling neurological disorder characterized by multiple phases:
premonitory, aura, headache, postdrome, and interictal. Our understanding of the …

A randomized trial of plasma exchange in acute central nervous system inflammatory demyelinating disease

BG Weinshenker, PC O'Brien, TM Petterson… - Annals of …, 1999 - Wiley Online Library
There are no established treatments for patients with acute, severe neurological deficits
caused by multiple sclerosis or other inflammatory demyelinating diseases of the central …

OnabotulinumtoxinA for treatment of chronic migraine: Pooled results from the double‐blind, randomized, placebo‐controlled phases of the PREEMPT clinical …

DW Dodick, CC Turkel, RE DeGryse… - … : The Journal of …, 2010 - Wiley Online Library
(Headache 2010; 50: 921‐936) Objective.—To assess the efficacy, safety, and tolerability of
onabotulinumtoxinA (BOTOX®) as headache prophylaxis in adults with chronic migraine …

[HTML][HTML] Fremanezumab for the preventive treatment of chronic migraine

SD Silberstein, DW Dodick, ME Bigal… - … England Journal of …, 2017 - Mass Medical Soc
Background Fremanezumab, a humanized monoclonal antibody targeting calcitonin gene–
related peptide (CGRP), is being investigated as a preventive treatment for migraine. We …

Efficacy and tolerability of MK-0974 (telcagepant), a new oral antagonist of calcitonin gene-related peptide receptor, compared with zolmitriptan for acute migraine: a …

TW Ho, MD Ferrari, DW Dodick, V Galet, J Kost, X Fan… - The Lancet, 2008 - thelancet.com
Background Calcitonin gene-related peptide (CGRP) probably has a role in migraine
pathophysiology, and antagonism of its receptors might provide treatment without the …

ARISE: a phase 3 randomized trial of erenumab for episodic migraine

DW Dodick, M Ashina, JL Brandes, D Kudrow… - …, 2018 - journals.sagepub.com
Background Calcitonin gene-related peptide plays an important role in migraine
pathophysiology. Erenumab, a human monoclonal antibody that inhibits the calcitonin gene …

Evaluation of galcanezumab for the prevention of episodic migraine: the EVOLVE-1 randomized clinical trial

VL Stauffer, DW Dodick, Q Zhang, JN Carter… - JAMA …, 2018 - jamanetwork.com
Importance Migraine is a disabling neurological disease characterized by severe headache
attacks. Treatment options reduce migraine frequency for many patients, but adverse effects …

Efficacy and safety of topiramate for the treatment of chronic migraine: A randomized, double‐blind, placebo‐controlled trial

SD Silberstein, RB Lipton, DW Dodick… - … : The Journal of …, 2007 - Wiley Online Library
Objective.—To evaluate the efficacy and safety of topiramate (100 mg/day) compared with
placebo for the treatment of chronic migraine. Methods.—This was a randomized, placebo …